Intellipharmaceutics International Inc. (IPCI)

[AngeloFoca]

Seroquel : as of 5th Jan - TRX Count
Mallinck 549 (previous weeks: 477 - 516 -648 -639) this is useful - also need for same weekly dates, #s in Seroquel XR $ SALES, and December 2017 monthly sales.

Focalin: as of 5th Jan - TRX Count
Par 3.97k (previous weeks: 3.65 - 4.88 -5.47 -5.73 -6.34) this is of no use... need monthly (December) sales $ only - never had that as weekly - If you provide me with the #s I'll update the spread sheet.

NOTE: Since the #s reported can't be counted on as being actual performance... we can use them only for trend lines.

HOWEVER... One encouraging thing is that since these #s don't reflect what actual sales are... then the IPCI royalty payments are apparently not the paultry %age split that the figures seemed to have suggested.

Therefore there is hope that IPCI's %age split is what I think it should be (at least 30% - possibly 40%) and IF MNK is able to capture a healthy 10% of Seroquel XR sales, then there is hope for sizeable royalty payments down the road... not only on Seroquel but Lamictal and Pristiq.